Wolverine Asset Management LLC Has $10.42 Million Position in Drugs Made In America Acquisition Corp. $DMAA

Wolverine Asset Management LLC grew its position in shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) by 69.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,021,906 shares of the company’s stock after purchasing an additional 418,868 shares during the quarter. Wolverine Asset Management LLC owned about 3.50% of Drugs Made In America Acquisition worth $10,423,000 as of its most recent SEC filing.

Separately, Mizuho Securities USA LLC bought a new stake in Drugs Made In America Acquisition in the 1st quarter valued at about $5,402,000.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Drugs Made In America Acquisition in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Drugs Made In America Acquisition currently has a consensus rating of “Sell”.

Drugs Made In America Acquisition Stock Performance

NASDAQ DMAA opened at $10.32 on Friday. Drugs Made In America Acquisition Corp. has a 1 year low of $9.95 and a 1 year high of $10.35. The business has a 50 day moving average price of $10.28.

Drugs Made In America Acquisition Company Profile

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.